Condition
Dysthymia
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 22 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
22 shownTransdiagnostic Internet-delivered Intervention for Adolescents With Anxiety and DepressionNCT06724666 · 2025-04-01
RECRUITINGOnline System for Identifying and Addressing Teen Depression in Primary CareNCT04489485 · 2021-02-01
UNKNOWNImplementation of Harmonized Depression Outcome Measures in a Health SystemNCT04235712 · 2020-11-17
COMPLETEDImplementation of Harmonized Depression Outcome Measures in a Primary Care Registry and a Mental Health RegistryNCT04235725 · 2020-03-15
COMPLETEDPramipexole to Target "Anhedonic Depression"NCT04121091 · 2019-10-04
COMPLETEDL-DOPA vs. Placebo for Depression and Psychomotor Slowing in Older AdultsNCT03761030 · 2019-01-09
TERMINATEDA Trial of Cognitive Behavioral Therapy in Familial DysautonomiaNCT03013777 · 2016-12-06
COMPLETEDA Study of L-DOPA for Depression and Slowing in Older AdultsNCT02744391 · 2016-08-24
COMPLETEDUsing Mental Health Telemetry to Predict Relapse and Re-hospitalization in Mood DisordersNCT01882608 · 2013-10-01
COMPLETEDDesvenlafaxine vs. Placebo Treatment of Chronic DepressionNCT01537068 · 2012-02-01
COMPLETEDA Stepped Care Model of Adolescent Depression Treatment in Primary CareNCT01443715 · 2011-09-01
COMPLETEDA Clinical Trial of IPT-A to Prevent Suicide in Depressed Adolescents With Suicidal BehaviorNCT01447602 · 2011-09-01
COMPLETEDSafety and Efficacy Study of Citalopram and Lithium for the Treatment of Depressive Mood Disorder SymptomsNCT01189812 · 2010-03-01
COMPLETEDYoga in Unipolar and Bipolar DisordersNCT00482482 · 2007-09-01
COMPLETEDProject to Improve Symptoms and Mood in People With Spinal Cord InjuryNCT00592384 · 2007-07-01
COMPLETEDDichotic Listening as a Predictor of Medication Response in DepressionNCT00404755 · 2006-07-01
COMPLETEDA Study of Omega-3 as a Treatment for Major DepressionNCT00238758 · 2005-10-01
UNKNOWNAre Two Antidepressants a Good Initial Treatment for Depression?NCT00296712 · 2005-02-01
COMPLETEDTreatment of Depression Following Multiple Brain TestsNCT00296777 · 2004-12-01
COMPLETEDTreating Depression Among Low-Income Patients With CancerNCT00565110 · 2004-06-01
COMPLETEDReliability and Validity of the MINI International Neuropsychiatric Interview for Children and Adolescents (MINI-KID)NCT00579267 · 2004-02-01
COMPLETEDDichotic Listening as a Predictor of Medication Response in DepressionNCT00296725 · 1994-04-01
COMPLETEDCommon interventions
ImipramineDRUG3placeboDRUG3BupropionDRUG2EscitalopramDRUG2Harmonized Depression Outcome MeasuresOTHER28-week CBT ProgramBEHAVIORAL1ADAPt-C interventionBEHAVIORAL1CitalopramDRUG1DesvenlafaxineDRUG1escitalopram + bupropionDRUG1FluoxetineDRUG1IPT-ABEHAVIORAL1L-DOPADRUG1LevodopaDRUG1Lithium CarbonateDRUG1Mental Health Telemetry (MHT)OTHER1MINI-KIDOTHER1Omega-3 Polyunsaturated Fatty AcidsDRUG1Placebo Oral TabletDRUG1Pramipexole PillDRUG1psychoeducationBEHAVIORAL1Stepped Care IPT-A (SCIPT-A)BEHAVIORAL1Teen Depression Module used for careBEHAVIORAL1Transdiagnostic Internet-delivered interventionBEHAVIORAL1Treatment as UsualBEHAVIORAL1
Leading sponsors
New York State Psychiatric Institute
9
OM1, Inc.
2
Babes-Bolyai University
1
Centre for Addiction and Mental Health
1
Columbia Northwest Pharmaceuticals
1
Dr. David Kreindler
1
NYU Langone Health
1
Region Skane
1
The University of New South Wales
1
Total Child Health, Inc.
1
University of South Florida
1
University of Southern California
1
University of Washington
1
Trial status mix
COMPLETED18
UNKNOWN2
RECRUITING1
TERMINATED1
Phase mix
PHASE47
NA5
PHASE25
PHASE32
PHASE11
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.